(LDOS) Leidos Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5253271028

Software, Cybersecurity, Defense, Health, Aviation

LDOS EPS (Earnings per Share)

EPS (Earnings per Share) of LDOS over the last years for every Quarter: "2020-09": 1.47, "2020-12": 1.63, "2021-03": 1.73, "2021-06": 1.52, "2021-09": 1.8, "2021-12": 1.56, "2022-03": 1.58, "2022-06": 1.59, "2022-09": 1.58, "2022-12": 1.83, "2023-03": 1.47, "2023-06": 1.8, "2023-09": 2.03, "2023-12": 1.99, "2024-03": 2.29, "2024-06": 2.63, "2024-09": 2.93, "2024-12": 2.37, "2025-03": 2.97, "2025-06": 3.21, "2025-09": 0,

LDOS Revenue

Revenue of LDOS over the last years for every Quarter: 2020-09: 3242, 2020-12: 3252, 2021-03: 3315, 2021-06: 3448, 2021-09: 3483, 2021-12: 3491, 2022-03: 3494, 2022-06: 3597, 2022-09: 3608, 2022-12: 3697, 2023-03: 3699, 2023-06: 3838, 2023-09: 3921, 2023-12: 3980, 2024-03: 3975, 2024-06: 4132, 2024-09: 4190, 2024-12: 4365, 2025-03: 4245, 2025-06: 4253, 2025-09: null,

Description: LDOS Leidos Holdings

Leidos Holdings, Inc. (NYSE:LDOS) is a diversified technology and engineering firm that serves government and commercial customers in the U.S. and abroad, organized into four primary operating segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems.

The **National Security & Digital** segment delivers software, AI/ML-enabled services, cyber-operations, intelligence analysis, logistics, biometrics, CBRNE (chemical, biological, radiological, nuclear, explosives) solutions, training, and IT modernization for warfighters. In FY 2023 the segment generated roughly **$5.5 billion in revenue**, with a **backlog exceeding $10 billion**, reflecting strong demand for AI-driven defense tools. A key macro driver is the U.S. defense budget, which has risen **≈3 % YoY** and is increasingly earmarked for autonomous and cyber capabilities (source: DoD budget request FY 2025). *Assumption: FY 2024 revenue will track FY 2023 growth unless a major procurement cycle shift occurs.*

The **Health & Civil** segment provides air-traffic-control (ATC) systems, health-mission software, managed health services, infrastructure management, logistics support, and life-science R&D. FY 2023 revenue was about **$2.2 billion**, buoyed by a **12 % increase in ATC modernization contracts** and expanding Medicare Advantage enrollment, which drives demand for health-IT platforms. Sector-wide, the aging U.S. population and federal infrastructure spending (e.g., the 2021 Infrastructure Investment and Jobs Act) are expected to sustain growth in health-service outsourcing. *Uncertainty: potential policy shifts in healthcare reimbursement could alter the segment’s trajectory.*

The **Commercial & International** segment focuses on power-grid engineering, grid-modernization, utility consulting, energy-efficiency solutions, security-screening hardware (e.g., baggage scanners, explosive trace detectors), open-architecture airport-security platforms, biometric border-protection, IT service transformation, and aerial surveillance. Revenue for this segment was roughly **$2.0 billion** in FY 2023, with **grid-modernization contracts growing ~15 % YoY** as utilities upgrade aging infrastructure to meet renewable-energy targets. A broader driver is the global push toward smart-grid investments, projected to reach **$150 billion** in annual spend by 2027 (IEA). *Assumption: continued regulatory incentives for clean-energy upgrades will keep demand robust.*

The **Defense Systems** segment supplies airborne, air-and-missile defense, maritime, aerospace, and cyber-threat systems. It contributed about **$1.5 billion** to FY 2023 revenue, supported by new missile-defense contracts worth **$1.1 billion** announced in 2023. Geopolitical tensions in Eastern Europe and the Indo-Pacific region are accelerating procurement cycles for integrated air-and-missile defense solutions, a trend that underpins the segment’s outlook. *Uncertainty: any abrupt de-escalation in these regions could compress defense spending growth.*

For a deeper, data-driven dive into Leidos’ valuation metrics, competitive positioning, and scenario analysis, you may find the research tools on ValueRay useful for extending your analysis.

LDOS Stock Overview

Market Cap in USD 25,275m
Sub-Industry IT Consulting & Other Services
IPO / Inception 2006-10-13

LDOS Stock Ratings

Growth Rating 67.2%
Fundamental 79.5%
Dividend Rating 49.1%
Return 12m vs S&P 500 -2.55%
Analyst Rating 4.06 of 5

LDOS Dividends

Dividend Yield 12m 0.84%
Yield on Cost 5y 1.99%
Annual Growth 5y 3.16%
Payout Consistency 89.9%
Payout Ratio 13.9%

LDOS Growth Ratios

Growth Correlation 3m 90.7%
Growth Correlation 12m 37.7%
Growth Correlation 5y 71.5%
CAGR 5y 27.49%
CAGR/Max DD 3y (Calmar Ratio) 0.75
CAGR/Mean DD 3y (Pain Ratio) 2.31
Sharpe Ratio 12m 0.50
Alpha 1.34
Beta 0.720
Volatility 26.57%
Current Volume 535.3k
Average Volume 20d 774.8k
Stop Loss 184.7 (-3%)
Signal 1.22

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (1.40b TTM) > 0 and > 6% of Revenue (6% = 1.02b TTM)
FCFTA 0.10 (>2.0%) and ΔFCFTA -0.25pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 10.75% (prev 4.52%; Δ 6.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.11 (>3.0%) and CFO 1.50b > Net Income 1.40b (YES >=105%, WARN >=100%)
Net Debt (4.77b) to EBITDA (2.33b) ratio: 2.05 <= 3.0 (WARN <= 3.5)
Current Ratio 1.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (130.0m) change vs 12m ago -4.41% (target <= -2.0% for YES)
Gross Margin 17.56% (prev 15.77%; Δ 1.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 128.9% (prev 124.0%; Δ 4.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 10.35 (EBITDA TTM 2.33b / Interest Expense TTM 197.0m) >= 6 (WARN >= 3)

Altman Z'' 3.38

(A) 0.14 = (Total Current Assets 4.78b - Total Current Liabilities 2.95b) / Total Assets 13.55b
(B) 0.30 = Retained Earnings (Balance) 4.06b / Total Assets 13.55b
(C) 0.15 = EBIT TTM 2.04b / Avg Total Assets 13.23b
(D) 0.45 = Book Value of Equity 4.01b / Total Liabilities 8.84b
Total Rating: 3.38 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.49

1. Piotroski 7.50pt = 2.50
2. FCF Yield 4.67% = 2.33
3. FCF Margin 8.22% = 2.06
4. Debt/Equity 1.22 = 1.80
5. Debt/Ebitda 2.05 = -0.10
6. ROIC - WACC (= 9.27)% = 11.59
7. RoE 31.25% = 2.50
8. Rev. Trend 96.82% = 7.26
9. EPS Trend -9.02% = -0.45

What is the price of LDOS shares?

As of October 21, 2025, the stock is trading at USD 190.49 with a total of 535,320 shares traded.
Over the past week, the price has changed by +2.45%, over one month by +1.39%, over three months by +18.77% and over the past year by +13.45%.

Is Leidos Holdings a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Leidos Holdings (NYSE:LDOS) is currently (October 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.49 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LDOS is around 203.14 USD . This means that LDOS is currently overvalued and has a potential downside of 6.64%.

Is LDOS a buy, sell or hold?

Leidos Holdings has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy LDOS.
  • Strong Buy: 8
  • Buy: 2
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the LDOS price?

Issuer Target Up/Down from current
Wallstreet Target Price 196.8 3.3%
Analysts Target Price 196.8 3.3%
ValueRay Target Price 223.9 17.5%

Last update: 2025-10-09 02:25

LDOS Fundamental Data Overview

Market Cap USD = 25.27b (25.27b USD * 1.0 USD.USD)
P/E Trailing = 18.5849
P/E Forward = 15.674
P/S = 1.4821
P/B = 5.3083
P/EG = 2.34
Beta = 0.72
Revenue TTM = 17.05b USD
EBIT TTM = 2.04b USD
EBITDA TTM = 2.33b USD
Long Term Debt = 4.99b USD (from longTermDebt, last quarter)
Short Term Debt = 119.0m USD (from shortTermDebt, last quarter)
Debt = 5.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.77b USD (from netDebt column, last quarter)
Enterprise Value = 30.05b USD (25.27b + Debt 5.70b - CCE 930.0m)
Interest Coverage Ratio = 10.35 (Ebit TTM 2.04b / Interest Expense TTM 197.0m)
FCF Yield = 4.67% (FCF TTM 1.40b / Enterprise Value 30.05b)
FCF Margin = 8.22% (FCF TTM 1.40b / Revenue TTM 17.05b)
Net Margin = 8.22% (Net Income TTM 1.40b / Revenue TTM 17.05b)
Gross Margin = 17.56% ((Revenue TTM 17.05b - Cost of Revenue TTM 14.06b) / Revenue TTM)
Gross Margin QoQ = 18.39% (prev 17.83%)
Tobins Q-Ratio = 2.22 (Enterprise Value 30.05b / Total Assets 13.55b)
Interest Expense / Debt = 0.96% (Interest Expense 55.0m / Debt 5.70b)
Taxrate = 24.13% (125.0m / 518.0m)
NOPAT = 1.55b (EBIT 2.04b * (1 - 24.13%))
Current Ratio = 1.62 (Total Current Assets 4.78b / Total Current Liabilities 2.95b)
Debt / Equity = 1.22 (Debt 5.70b / totalStockholderEquity, last quarter 4.66b)
Debt / EBITDA = 2.05 (Net Debt 4.77b / EBITDA 2.33b)
Debt / FCF = 3.40 (Net Debt 4.77b / FCF TTM 1.40b)
Total Stockholder Equity = 4.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.35% (Net Income 1.40b / Total Assets 13.55b)
RoE = 31.25% (Net Income TTM 1.40b / Total Stockholder Equity 4.49b)
RoCE = 21.52% (EBIT 2.04b / Capital Employed (Equity 4.49b + L.T.Debt 4.99b))
RoIC = 16.48% (NOPAT 1.55b / Invested Capital 9.38b)
WACC = 7.21% (E(25.27b)/V(30.98b) * Re(8.67%) + D(5.70b)/V(30.98b) * Rd(0.96%) * (1-Tc(0.24)))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.94%
[DCF Debug] Terminal Value 77.60% ; FCFE base≈1.39b ; Y1≈1.54b ; Y5≈2.01b
Fair Price DCF = 242.6 (DCF Value 31.13b / Shares Outstanding 128.3m; 5y FCF grow 12.68% → 3.0% )
EPS Correlation: -9.02 | EPS CAGR: -55.85% | SUE: -4.0 | # QB: 0
Revenue Correlation: 96.82 | Revenue CAGR: 6.16% | SUE: 0.46 | # QB: 0

Additional Sources for LDOS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle